Trial record 5 of 8 for:    Ixmyelocel-T

Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01020968
Recruitment Status : Completed
First Posted : November 26, 2009
Last Update Posted : August 7, 2018
Information provided by (Responsible Party):
Vericel Corporation

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2013
  Actual Study Completion Date : December 2013
  Certification/Extension First Submitted : June 27, 2016